Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation

Peroxisome proliferator-activated receptor (PPAR) agonists have been suggested as novel therapeutics for the treatment of inflammatory lung disease, such as allergic asthma. Treatment with PPAR agonists has been shown to inhibit airway eosinophilia in murine models of allergic asthma, which can occu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, Steven G, Hill, Mike, Oliveria, John-Paul, Watson, Brittany M, Baatjes, Adrian J, Dua, Benny, Howie, Karen, Campbell, Heather, Watson, Rick M, Sehmi, Roma, Gauvreau, Gail M
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2014
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080964/
https://ncbi.nlm.nih.gov/pubmed/24628018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12280
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars